GoodRx Holdings, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
GoodRx Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • GoodRx Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $7.82M, a 86.3% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $7.82M -$49.3M -86.3% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $57.1M +$4.44M +8.42% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $52.7M +$52.4M +19556% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $268K -$293K -52.2% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $561K Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.